Stocktoria
MIMEDX GROUP, INC. MDXG
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-08-20
MIMEDX GROUP, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $418.6M | $348.9M | $321.5M | $267.8M | $242.0M | $248.2M | $299.3M | $359.1M | $321.1M | $221.7M |
| Gross profit | $345.6M | $288.8M | $266.8M | $219.5M | $202.4M | $208.9M | $256.2M | $322.7M | $285.9M | $190.8M |
| R&D expense | $15.1M | $12.3M | $12.7M | $12.7M | $9.9M | $11.7M | $11.1M | $15.8M | $17.9M | $14.3M |
| SG&A expense | $266.2M | $225.1M | $211.1M | $208.7M | $194.8M | $181.0M | $198.2M | $258.5M | $220.1M | $173.4M |
| Operating income | $63.9M | $58.9M | $37.1M | -$14.7M | -$7.1M | -$45.4M | -$21.2M | -$3.9M | $46.2M | $884,000 |
| Interest expense | — | — | — | — | — | — | — | — | — | $339,000 |
| Income tax | $17.7M | $15.3M | -$36.8M | $206,000 | $247,000 | -$12.3M | -$5,000 | $26.6M | -$19.6M | $155,000 |
| Net income | $48.6M | $42.4M | $58.2M | -$30.2M | -$10.3M | -$49.3M | -$25.6M | -$30.0M | $64.7M | $390,000 |
| EPS (diluted) | $0.32 | $0.28 | $0.37 | $-0.33 | $-0.15 | $-0.77 | $-0.24 | $-0.28 | $0.56 | $0.00 |
| Operating cash flow | $74.0M | $67.1M | $34.9M | -$17.9M | -$9.9M | -$30.3M | -$39.4M | $35.8M | $62.9M | $23.8M |
| Free cash flow | — | — | $33.0M | -$19.4M | -$13.1M | — | — | — | — | — |
| Cash & equivalents | $166.1M | $104.4M | $82.0M | $66.0M | $87.1M | $95.8M | $69.1M | $45.1M | $27.5M | $30.3M |
| Inventory | $25.3M | $23.8M | $21.0M | $13.2M | $11.4M | $10.4M | $9.1M | $16.0M | $9.5M | $15.9M |
| Total assets | $342.7M | $263.9M | $239.0M | $171.4M | $187.9M | $202.0M | $167.2M | $122.8M | $121.3M | $117.3M |
| Total liabilities | $86.1M | $70.8M | $96.3M | $96.9M | $95.4M | $110.6M | $132.8M | $73.2M | $47.5M | $69.2M |
| Shareholders' equity | $256.5M | $193.1M | $142.7M | -$18.0M | $82,000 | -$150,000 | $34.4M | $49.7M | $73.8M | $48.1M |
Growth · year-over-year · Revenue CAGR 7.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +20.0% | +8.5% | +20.0% | +10.7% | -2.5% | -17.0% | -16.7% | +11.8% | +44.8% | — |
| Net income growth | +14.5% | -27.2% | — | — | — | — | — | -146.3% | +16496.7% | — |
| EPS growth | +14.3% | -24.3% | — | — | — | — | — | -150.0% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.